Search

everythinglearnresearchcommunity

for

Search:↓

Aminoacridine and Abemaciclib, especially combined with Minoxidil, show promise for treating hair loss.

The correction states that the label change for Finasteride was in 2012, leading to more reports of side effects from non-healthcare people.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

The study explored a possible link between finasteride use and suicide.

Finasteride use for hair loss is linked to an increased risk of suicidal thoughts and a higher risk of suicide.

Finasteride, a hair loss drug, is linked to increased suicidal thoughts, particularly when used for hair loss.

Lasers are less favored for hair transplant surgery but show promise for hair growth in controlled trials.

Hair loss can be managed and sometimes reversed with certain drugs, but not permanently cured.

Biotechnology could lead to new hair growth products.

Robotic-assisted hair transplant is effective and less painful, but needs more evaluation for long-term results.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Finasteride's effectiveness on the frontal hair loss area is not well-studied or confirmed.

Photography helps track hair loss and supports treatment approvals.

Propecia is a top non-surgical treatment for hair loss, especially when combined with hair transplants.

Early treatment with finasteride and minoxidil can effectively reverse hereditary hair loss.

Spironolactone is safe for breast cancer survivors with alopecia and does not increase cancer risk.

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

Dutasteride's effect on hair loss treatment is uncertain and should be used cautiously.

Public interest in finasteride's sexual side effects has significantly increased.

Microneedling may be an effective treatment for pattern hair loss.

Dermatologists can use social media to better educate people about hair loss treatments.

Finasteride toxicity information is limited, poor quality, and biased.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.